Exane Derivatives’s W.W. Grainger GWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$177K Sell
390
-880
-69% -$428K 0.1% 189
2022
Q1
$655K Buy
1,270
+590
+87% +$290K 0.18% 146
2021
Q4
$352K Sell
680
-81
-11% -$38.2K 0.09% 233
2021
Q3
$299K Sell
761
-840
-52% -$365K 0.07% 287
2021
Q2
$729K Buy
1,601
+1,595
+26,583% +$704K 0.17% 122
2021
Q1
$2.41K Hold
6
﹤0.01% 664
2020
Q4
$2.45K Hold
6
﹤0.01% 606
2020
Q3
$2.14K Hold
6
﹤0.01% 557
2020
Q2
$1.89K Hold
6
﹤0.01% 509
2020
Q1
$1.49K Hold
6
﹤0.01% 521
2019
Q4
$2.04K Hold
6
﹤0.01% 496
2019
Q3
$1.78K Hold
6
﹤0.01% 502
2019
Q2
$1.61K Hold
6
﹤0.01% 523
2019
Q1
$1.8K Hold
6
﹤0.01% 458
2018
Q4
$1.69K Hold
6
﹤0.01% 534
2018
Q3
$2.14K Sell
6
-95
-94% -$32.7K ﹤0.01% 491
2018
Q2
$31.1K Sell
101
-8,765
-99% -$2.62M 0.01% 408
2018
Q1
$2.46M Buy
8,866
+5,359
+153% +$1.4M 0.49% 43
2017
Q4
$828K Buy
3,507
+2,946
+525% +$609K 0.14% 117
2017
Q3
$101K Buy
+561
New +$94.6K 0.02% 256

Other funds holding GWW

Exane Derivatives's GWW Position: Q2 2022 in Review

Exane Derivatives reduced its W.W. Grainger (GWW) stake by 69% in Q2 2022, selling an estimated $428K and leaving 390 shares worth $177K. The position accounts for 0.1% of the portfolio, ranked #189.

Exane Derivatives first reported a position in GWW in Q3 2017 and has held it in 20 quarters since. The position peaked at $2.46M in Q1 2018. 860 funds tracked by Wall St. Rank hold GWW as of Q2 2022.

  • Exane Derivatives held 390 shares of W.W. Grainger worth $177K as of Q2 2022.
  • Exane Derivatives sold 880 W.W. Grainger shares in Q2 2022, an estimated $428K.
  • W.W. Grainger made up 0.1% of Exane Derivatives's portfolio in Q2 2022, its #189 holding.
  • Exane Derivatives first reported a position in W.W. Grainger in Q3 2017 and has held it in 20 quarters since.
  • Exane Derivatives's W.W. Grainger position peaked at $2.46M in Q1 2018.
  • 860 funds tracked by Wall St. Rank held W.W. Grainger as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.